Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Abstract 4561: Oncolytic vaccinia virus encoding IL-7 and IL-12 systemically sensitizes tumors to anti-PD-1 antibody in a syngeneic mouse model

Shinsuke Nakao, Midori Yamashita, Mamoru Tasaki, Tatsuya Kawase, Motomu Nakatake, Hajime Kurosaki, Masamichi Mori, Masahiro Takeuchi, Takafumi Nakamura

Cancer Res (2020) 80 (16_Supplement): 4561.

https://doi.org/10.1158/1538-7445.AM2020-4561

Published: 15 August 2020

View articletitled, Abstract 4561: Oncolytic vaccinia virus encoding IL-7 and IL-12 systemically sensitizes tumors to anti-PD-1 antibody in a syngeneic mouse model

Journal Articles

Abstract 4638: The p53 suppression on tumor cells may recruit macrophages and modulate their expression of the indoleamine 2, 3-dioxygenase

Takafumi Nakamura

Cancer Res (2017) 77 (13_Supplement): 4638.

https://doi.org/10.1158/1538-7445.AM2017-4638

Published: 01 July 2017

View articletitled, Abstract 4638: The p53 suppression on tumor cells may recruit macrophages and modulate their expression of the indoleamine 2, 3-dioxygenase

Journal Articles

Abstract 4713: A Kampo (Japanese herbal) medicine Juzentaihoto may suppress the expression of indoleamine 2, 3-dioxygenase on macrophages and prolong the survival of transgenic mice bearing lens-epithelial cell carcinoma.

Takafumi Nakamura

Cancer Res (2013) 73 (8_Supplement): 4713.

https://doi.org/10.1158/1538-7445.AM2013-4713

Published: 15 April 2013

View articletitled, Abstract 4713: A Kampo (Japanese herbal) medicine Juzentaihoto may suppress the expression of indoleamine 2, 3-dioxygenase on macrophages and prolong the survival of transgenic mice bearing lens-epithelial cell carcinoma.

Journal Articles

Coxsackievirus B3 Is an Oncolytic Virus with Immunostimulatory Properties That Is Active against Lung Adenocarcinoma

Shohei Miyamoto, Hiroyuki Inoue, Takafumi Nakamura, Meiko Yamada, Chika Sakamoto, Yasuo Urata, Toshihiko Okazaki, Tomotoshi Marumoto, Atsushi Takahashi, Koichi Takayama, Yoichi Nakanishi, Hiroyuki Shimizu, Kenzaburo Tani

Cancer Res (2012) 72 (10): 2609–2621.

https://doi.org/10.1158/0008-5472.CAN-11-3185

Published: 14 May 2012

View articletitled, Coxsackievirus B3 Is an Oncolytic Virus with Immunostimulatory Properties That Is Active against Lung Adenocarcinoma

Includes: Supplementary data

Journal Articles

Abstract LB-369: Coxsackievirus B3 is an immunostimulatory oncolytic virus active against lung adenocarcinoma

Shohei Miyamoto, Hiroyuki Inoue, Beibei Wang, Keisuke Yasunari, Takafumi Nakamura, Meiko Yamada, Yasuo Urata, Tomotoshi Marumoto, Atsushi Takahashi, Koichi Takayama, Yoichi Nakanishi, Hiroyuki Shimizu, Kenzaburo Tani

Cancer Res (2012) 72 (8_Supplement): LB-369.

https://doi.org/10.1158/1538-7445.AM2012-LB-369

Published: 15 April 2012

View articletitled, Abstract LB-369: Coxsackievirus B3 is an immunostimulatory oncolytic virus active against lung adenocarcinoma

Journal Articles

Tumor and Vascular Targeting of a Novel Oncolytic Measles Virus Retargeted against the Urokinase Receptor

Yuqi Jing, Caili Tong, Jin Zhang, Takafumi Nakamura, Ianko Iankov, Stephen J. Russell, Jaime R. Merchan

Cancer Res (2009) 69 (4): 1459–1468.

https://doi.org/10.1158/0008-5472.CAN-08-2628

Published: 12 February 2009

View articletitled, Tumor and Vascular Targeting of a Novel Oncolytic Measles Virus Retargeted against the Urokinase Receptor

Includes: Supplementary data

Journal Articles

Targeted release of oncolytic measles virus by blood outgrowth endothelial cells in situ inhibits orthotopic gliomas

Jiwu Wei, Joachim Wahl, Takafumi Nakamura, Detlef Stiller, Klaus-Michael Debatin, Christian Beltinger

Cancer Res (2007) 67 (9_Supplement): 4185.

Published: 01 May 2007

View articletitled, Targeted release of oncolytic measles virus by blood outgrowth endothelial cells in situ inhibits orthotopic gliomas

Journal Articles

Retargeted Oncolytic Measles Strains Entering via the EGFRvIII Receptor Maintain Significant Antitumor Activity against Gliomas with Increased Tumor Specificity

Cory Allen, Sompong Vongpunsawad, Takafumi Nakamura, C. David James, Mark Schroeder, Roberto Cattaneo, Caterina Giannini, James Krempski, Kah-Whye Peng, Jenny M. Goble, Joon H. Uhm, Stephen J. Russell, Evanthia Galanis

Cancer Res (2006) 66 (24): 11840–11850.

https://doi.org/10.1158/0008-5472.CAN-06-1200

Published: 18 December 2006

View articletitled, Retargeted Oncolytic Measles Strains Entering via the EGFRvIII Receptor Maintain Significant Antitumor Activity against Gliomas with Increased Tumor Specificity

Includes: Supplementary data

Journal Articles

Overexpression of both wild-type human p53 and Retinoblastoma protein may suppress the initiation and the progression of epithelial cell carcinoma induced by SV 40 T antigens in transgenic mice

Takafumi Nakamura, Shigeru Saito, Heiner Westphal

Cancer Res (2006) 66 (8_Supplement): 522–523.

Published: 15 April 2006

View articletitled, Overexpression of both wild-type human p53 and Retinoblastoma protein may suppress the initiation and the progression of epithelial cell carcinoma induced by SV 40 T antigens in transgenic mice

Journal Articles

Oncolytic virotherapy for targeting ovarian cancer using fully folate receptor targeted recombinant measles virus

Kosei Hasegawa, Takafumi Nakamura, Mary Harvey, Atsushi Hongo, Mariangela Figini, Silvana Canervari, Kah-Whye Peng

Cancer Res (2006) 66 (8_Supplement): 947.

Published: 15 April 2006

View articletitled, Oncolytic virotherapy for targeting ovarian cancer using fully folate receptor targeted recombinant measles virus

Journal Articles

Fully retargeted measles viruses for cancer therapy

Takafumi Nakamura, Kah-Whye Peng, Mary Harvey, Suzanne Greiner, Stephen J. Russell

Cancer Res (2005) 65 (9_Supplement): 1252.

Published: 01 May 2005

View articletitled, Fully retargeted measles viruses for cancer therapy

Journal Articles

The human wild-type p53 transgene expressing lens epithelial tumors will be suppressed by methylation of promoter region in transgenic mice

Takafumi Nakamura, Shigeru Saito, Heiner Westphal

Cancer Res (2005) 65 (9_Supplement): 921.

Published: 01 May 2005

View articletitled, The human wild-type p53 transgene expressing lens epithelial tumors will be suppressed by methylation of promoter region in transgenic mice

Journal Articles

High CD46 Receptor Density Determines Preferential Killing of Tumor Cells by Oncolytic Measles Virus

Bambi D. Anderson, Takafumi Nakamura, Stephen J. Russell, Kah-Whye Peng

Cancer Res (2004) 64 (14): 4919–4926.

https://doi.org/10.1158/0008-5472.CAN-04-0884

Published: 15 July 2004

View articletitled, High CD46 Receptor Density Determines Preferential Killing of Tumor Cells by Oncolytic Measles Virus

Journal Articles

SV40 T antigens induce carcinoma, sarcoma and mesothelioma at various sites in the transgenic mice

Takafumi Nakamura, Shigeru Saito, Heiner Westphal

Cancer Res (2004) 64 (7_Supplement): 353.

Published: 01 April 2004

View articletitled, SV40 T antigens induce carcinoma, sarcoma and mesothelioma at various sites in the transgenic mice

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 4561: Oncolytic vaccinia virus encoding IL-7 and IL-12 systemically sensitizes tumors to anti-PD-1 antibody in a syngeneic mouse model

Abstract 4638: The p53 suppression on tumor cells may recruit macrophages and modulate their expression of the indoleamine 2, 3-dioxygenase

Abstract 4713: A Kampo (Japanese herbal) medicine Juzentaihoto may suppress the expression of indoleamine 2, 3-dioxygenase on macrophages and prolong the survival of transgenic mice bearing lens-epithelial cell carcinoma.

Coxsackievirus B3 Is an Oncolytic Virus with Immunostimulatory Properties That Is Active against Lung Adenocarcinoma

Abstract LB-369: Coxsackievirus B3 is an immunostimulatory oncolytic virus active against lung adenocarcinoma

Tumor and Vascular Targeting of a Novel Oncolytic Measles Virus Retargeted against the Urokinase Receptor

Targeted release of oncolytic measles virus by blood outgrowth endothelial cells in situ inhibits orthotopic gliomas

Retargeted Oncolytic Measles Strains Entering via the EGFRvIII Receptor Maintain Significant Antitumor Activity against Gliomas with Increased Tumor Specificity

Overexpression of both wild-type human p53 and Retinoblastoma protein may suppress the initiation and the progression of epithelial cell carcinoma induced by SV 40 T antigens in transgenic mice

Oncolytic virotherapy for targeting ovarian cancer using fully folate receptor targeted recombinant measles virus

Fully retargeted measles viruses for cancer therapy

The human wild-type p53 transgene expressing lens epithelial tumors will be suppressed by methylation of promoter region in transgenic mice

High CD46 Receptor Density Determines Preferential Killing of Tumor Cells by Oncolytic Measles Virus

SV40 T antigens induce carcinoma, sarcoma and mesothelioma at various sites in the transgenic mice

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only